☆ 4.5 Article

Impact of axillary surgery on outcome of clinically node positive breast cancer treated with neoadjuvant chemotherapy

BREAST CANCER RESEARCH AND TREATMENT (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Oncology

Omission of Axillary Lymph Node Dissection is Associated with Inferior Survival in Breast Cancer Patients with Residual N1 Nodal Disease Following Neoadjuvant Chemotherapy

Muayad F. Almahariq et al.

Summary: The study compared the survival outcomes of breast cancer patients with residual lymph node disease who underwent sentinel lymph node dissection (SLND) or axillary lymph node dissection (ALND) using the National Cancer Database (NCDB). The results showed that SLND was associated with lower survival rates compared to ALND in matched cohorts, suggesting that ALND may be preferred over SLND for patients with residual lymph node disease. Further prospective trials are needed to confirm the efficacy of SLND in this patient population.

ANNALS OF SURGICAL ONCOLOGY (2021)

添加到收藏夹

Article Oncology

Oncologic Safety of Sentinel Lymph Node Biopsy Alone After Neoadjuvant Chemotherapy for Breast Cancer

Stephanie M. Wong et al.

Summary: This study demonstrates that sentinel lymph node biopsy alone for patients who convert to pathologic node-negativity after neoadjuvant chemotherapy is associated with low short-term axillary recurrence rates. Additional follow-up data from prospective clinical trials are needed to confirm long-term oncologic safety and optimal local therapy recommendations.

ANNALS OF SURGICAL ONCOLOGY (2021)

添加到收藏夹

Article Oncology

Long-term standard sentinel node biopsy after neoadjuvant treatment in breast cancer: a single institution ten-year follow-up

Sabrina Kahler-Ribeiro-Fontana et al.

Summary: This study evaluated the outcomes of patients undergoing NAT who remained or converted to cN0 and received SNB, showing a high overall survival rate after 10-year follow-up. The use of standard SNB in cN1/2 patients who become cN0 after NAT was deemed acceptable and did not result in worse outcomes.

EJSO (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Sentinel node biopsy alone for breast cancer patients with residual nodal disease after neoadjuvant chemotherapy

Jung Whan Chun et al.

Summary: This study analyzed the long-term outcomes of patients with residual N1 nodal disease following neoadjuvant chemotherapy for breast cancer and found that omission of axillary lymph node dissection using propensity score matching was oncologically safe. No significant differences in axillary recurrence-free survival, distant metastasis-free survival, overall survival, and breast cancer-free survival were observed between SLNB only group and ALND group after propensity score matching.

SCIENTIFIC REPORTS (2021)

添加到收藏夹

Article Oncology

Regional Recurrence Rates With or Without Complete Axillary Dissection for Breast Cancer Patients with Node-Positive Disease on Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy

Diane C. Ling et al.

ADVANCES IN RADIATION ONCOLOGY (2020)

添加到收藏夹

Article Oncology

Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study

Jean-Marc Classe et al.

BREAST CANCER RESEARCH AND TREATMENT (2019)

添加到收藏夹

Review Surgery

Meta-analysis of sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with initial biopsy-proven node-positive breast cancer

S. R. Tee et al.

BRITISH JOURNAL OF SURGERY (2018)

添加到收藏夹

Article Medicine, Research & Experimental

Tailored axillary surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (TAXIS): study protocol for a multicenter, randomized phase-III trial

Guido Henke et al.

TRIALS (2018)

添加到收藏夹

Article Oncology

Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection

Abigail S. Caudle et al.

JOURNAL OF CLINICAL ONCOLOGY (2016)

添加到收藏夹

Article Oncology

Sentinel Node Biopsy After Neoadjuvant Chemotherapy in Biopsy-Proven Node-Positive Breast Cancer: The SN FNAC Study

Jean-Francois Boileau et al.

JOURNAL OF CLINICAL ONCOLOGY (2015)

添加到收藏夹

Article Medicine, General & Internal

Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer The ACOSOG Z1071 (Alliance) Clinical Trial

Judy C. Boughey et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)

添加到收藏夹

Article Oncology

Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study

Thorsten Kuehn et al.

LANCET ONCOLOGY (2013)

添加到收藏夹

Article Oncology

Predictors of Locoregional Recurrence After Neoadjuvant Chemotherapy: Results From Combined Analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27

Eleftherios P. Mamounas et al.

JOURNAL OF CLINICAL ONCOLOGY (2012)

添加到收藏夹

Article Surgery

Management and outcomes of isolated axillary node recurrence in breast cancer

David E. Konkin et al.

ARCHIVES OF SURGERY (2006)

添加到收藏夹

Article Surgery

Axillary recurrence rate in breast cancer patients with negative sentinel lymph node (SLN) or SLN micrometastases - Prospective analysis of 150 patients after SLN biopsy

I Langer et al.

ANNALS OF SURGERY (2005)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.